Sales of GenScript`s Anti-His Monoclonal Antibody Increase 600 per cent in 2008
Released on: August 25, 2008, 11:03 pm
Press Release Author: Sally Wang
Industry: Biotech
Press Release Summary: High quality Anti-His Monoclonal antibody developed Genscript has been widely accepted in the field.
Press Release Body: PISCATAWAY, N.J.,Aug. 26, 2008 - GenScript Corporation has once again proven its status as a reliable supplier of the highest quality biological reagents.
GenScript developed and manufactures a highly sensitive anti-His monoclonal antibody (cat # A00186) that recognizes polyhistidine tags placed at N-terminal, C-terminal, or internal regions of fusion proteins. Noticeably, this antibody also recognizes 4XHis- and 5XHis-tags. This means that even if the 6xHis-tag is only partially exposed, it will still be recognized and detected by this antibody. GenScript's anti-His monoclonal antibody is well-suited for Westerns, IHC, preparation of protein purification resins, beads, detection kits and other products. The antibody is also available in biotin and HRP-conjugated forms.
To demonstrate its high confidence in the sensitivity and quality of the anti-His, GenScript offers free 10 ug samples of all three versions of this antibody.
Many biotech companies have already switched to GenScript as their sole supplier of anti-His antibodies. The popularity of GenScript's anti-His grows every month, leading to a more than 600% increase in anti-His sales since March 2008.
GenScript Corporation is a reliable outsourcing partner providing a wide array of services to augment all stages of drug discovery and biological reagent manufacturing processes, including high-quality gene synthesis and cloning, custom protein expression and purification, custom peptide synthesis and antibody development, custom stable cell line development, and a wide selection of biological reagents to life science researchers in industrial and academic settings. GenScript Corporation is headquartered in Piscataway, New Jersey. ###
2025
